Institutional Ownership Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN). We have compiled data on the 184 institutions that hold shares in the stock, with a total of 81.6 Million shares, which have been reported (via 13F filing form) to have a value of $2.35 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Deep Track Capital, LP
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
5,380,449
shares
|
$155 Million
3.65% of portfolio
|
Q1 2025
Added 18.96%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,773,622
shares
|
$137 Million
0.0% of portfolio
|
Q2 2024
Added 25.21%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2025 Q3 2025 |
4,427,927
shares
|
$127 Million
8.05% of portfolio
|
Q2 2025
Reduced 5.79%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
4,331,983
shares
|
$125 Million
0.0% of portfolio
|
Q3 2025
Reduced 3.92%
|
|
|
Vr Adviser, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
3,882,709
shares
|
$112 Million
12.69% of portfolio
|
Q3 2024
Added 0.0%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
Nov 14, 2025 Q3 2025 |
3,459,913
shares
|
$99.4 Million
16.2% of portfolio
|
Q2 2025
Added 0.41%
|
|
|
Commodore Capital LP
New York, NY |
Nov 14, 2025 Q3 2025 |
3,200,000
shares
|
$92 Million
4.39% of portfolio
|
Q3 2025
Reduced 34.36%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
2,842,925
shares
|
$81.7 Million
2.78% of portfolio
|
Q2 2025
Added 1.79%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,609,353
shares
|
$75 Million
1.81% of portfolio
|
Q3 2025
Reduced 4.82%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
2,554,166
shares
|
$73.4 Million
0.0% of portfolio
|
Q3 2025
Added 0.03%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
2,418,104
shares
|
$69.5 Million
0.01% of portfolio
|
Q3 2025
Reduced 16.48%
|
|
|
Novo Holdings
Hellerup, G7 |
Nov 14, 2025 Q3 2025 |
2,380,000
shares
|
$68.4 Million
4.15% of portfolio
|
Q2 2025
Added 5.76%
|
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
Nov 14, 2025 Q3 2025 |
2,212,701
shares
|
$63.6 Million
0.7% of portfolio
|
Q3 2025
Reduced 1.96%
|
|
|
Eversept Partners, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,924,306
shares
|
$55.3 Million
3.21% of portfolio
|
Q3 2025
Added 1.14%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
1,859,458
shares
|
$53.4 Million
0.01% of portfolio
|
Q3 2025
Reduced 4.35%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,766,187
shares
|
$50.8 Million
0.0% of portfolio
|
Q3 2025
Added 1.47%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,744,406
shares
|
$50.1 Million
0.31% of portfolio
|
Q2 2025
New holding
|
|
|
Loomis Sayles & CO L P
|
Nov 13, 2025 Q3 2025 |
1,550,328
shares
|
$44.6 Million
0.04% of portfolio
|
Q3 2025
Added 15.83%
|
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,462,400
shares
|
$42 Million
0.07% of portfolio
|
Q3 2025
Added 226.79%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,220,128
shares
|
$35.1 Million
0.04% of portfolio
|
Q3 2025
Added 10.06%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Nov 12, 2025 Q3 2025 |
1,201,226
shares
|
$34.5 Million
0.01% of portfolio
|
Q3 2025
Added 135.55%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
1,154,487
shares
|
$33.2 Million
3.11% of portfolio
|
Q3 2025
Reduced 11.11%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,122,532
shares
|
$32.3 Million
0.0% of portfolio
|
Q3 2025
Added 314.92%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,061,517
shares
|
$30.5 Million
0.03% of portfolio
|
Q2 2023
Added 1.78%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 18, 2025 Q3 2025 |
1,049,385
shares
|
$30.2 Million
0.02% of portfolio
|
Q3 2025
Reduced 17.09%
|
|